Delayed ventricular septal rupture after percutaneous coronary intervention in acute myocardial infarction

Ji Young Park1, Seong Hoon Park, Ji Young Oh

  • 1Division of Cardiology, Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.

Insights

Delayed ventricular septal rupture occurred 20 days after acute myocardial infarction treatment. This rare complication happened despite successful percutaneous coronary intervention and improved heart function, highlighting a potential delayed risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Ventricular septal rupture (VSR) is a rare but serious complication of acute myocardial infarction (AMI).
  • Historically, VSR occurred in approximately 1-3% of AMIs before reperfusion therapy, typically 3-5 days post-event.
  • A correlation exists between VSR incidence and coronary artery occlusion severity.

Observation:

  • A 70-year-old female presented with acute anterior myocardial infarction (MI) and recent cerebral infarction.
  • Coronary angiography revealed 90% stenosis in the left anterior descending artery (LAD), treated successfully with percutaneous coronary intervention (PCI) and stent implantation.
  • Despite initial improvement in anterior wall motion post-PCI, the patient suddenly deteriorated on day 20 with pulmonary congestion.

Findings:

  • Echocardiography identified a 1.3 cm ventricular septal defect (VSD) in the apical septum with a left-to-right shunt.
  • This represents a rare case of delayed septal rupture occurring 20 days after PCI in a patient with a patent LAD and recovered wall motion.

Implications:

  • This case underscores the possibility of delayed VSR even after successful revascularization and initial recovery.
  • It highlights the need for continued vigilance and monitoring for uncommon complications following acute myocardial infarction management.
  • Further research may be warranted to understand the mechanisms and risk factors for late-onset VSR in the context of modern interventional therapies.